Valuation check: KDMN's profit margin is -761.18%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2021
Trailing 12 months ending Sep 2021
The latest profit margin for KDMN is -761.18% as of September 2021. That compares with -785.72% in the prior-year period — up 3.1% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Kadmon Holdings's historical trend and sector peers before judging valuation or financial health.
Over the past year, KDMN's profit margin moved from -785.72% to -761.18% — a 3.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kadmon Holdings's valuation or profitability profile.
Against Healthcare companies, KDMN currently prints -761.18% for profit margin, while the sector average sits near 15.58%. That is roughly 4984.3% below the sector mean. Large gaps often invite a closer look at Kadmon Holdings's growth, margins, and balance sheet.
Profit Margin shows how effectively Kadmon Holdings converts resources into returns. At -761.18%, KDMN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -785.72% in the prior-year period — up 3.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting KDMN's profit margin (-761.18%), review year-over-year change from -785.72%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.